These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6509268

  • 1. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE, Bender W, Mayr H, Niederschweiberer A, Schmauss M.
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [Abstract] [Full Text] [Related]

  • 2. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A, Alcser K, Grunhaus L, Greden JF.
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [Abstract] [Full Text] [Related]

  • 3. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment.
    Dratcu L, Calil HM.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 May; 13(1-2):99-117. PubMed ID: 2748868
    [Abstract] [Full Text] [Related]

  • 4. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK, Bjørum N, Kirkegaard C, Aggernaes H, Krog-Meyer I, Lund-Laursen AM, Mikkelsen PL.
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [Abstract] [Full Text] [Related]

  • 5. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
    Kasper S, Beckmann H.
    Acta Psychiatr Scand; 1983 Jul; 68(1):31-7. PubMed ID: 6613617
    [Abstract] [Full Text] [Related]

  • 6. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M, De Ruyter M, Suy E.
    Psychoneuroendocrinology; 1989 Jul; 14(3):231-9. PubMed ID: 2756075
    [Abstract] [Full Text] [Related]

  • 7. Depression and the Newcastle Scale. Their relationship to the dexamethasone suppression test.
    Holden NL.
    Br J Psychiatry; 1983 May; 142():505-7. PubMed ID: 6871564
    [Abstract] [Full Text] [Related]

  • 8. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
    Philipp M, Maier W, Holsboer F.
    Psychoneuroendocrinology; 1986 May; 11(4):499-507. PubMed ID: 3562743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The dexamethasone suppression test in adolescent psychiatric patients.
    Ha H, Kaplan S, Foley C.
    Am J Psychiatry; 1984 Mar; 141(3):421-3. PubMed ID: 6703110
    [Abstract] [Full Text] [Related]

  • 14. The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry.
    Berger M, Pirke KM, Doerr P, Krieg JC, von Zerssen D.
    Br J Psychiatry; 1984 Oct; 145():372-82. PubMed ID: 6487910
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The research diagnostic criteria for endogenous depression and the dexamethasone suppression test: a discriminant function analysis.
    Zimmerman M, Stangl D, Coryell W.
    Psychiatry Res; 1985 Mar; 14(3):197-208. PubMed ID: 3858892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.